NasdaqGS:CYTKBiotechs
Cautious Look At Cytokinetics (CYTK) Valuation After Recent Share Price Pullback
What recent performance says about Cytokinetics
Cytokinetics (CYTK) has been on many watchlists after recent trading, with the stock showing a 1 day return of 1.22% and a modest 0.20% move over the past week.
Over longer periods, the share price shows a 10.29% decline over the past month and a 3.70% decline over the past 3 months, while the 1 year total return stands at 30.88%.
See our latest analysis for Cytokinetics.
That recent share price pullback, including a 10.29% 1 month share price...